ProfileGDS5678 / 1422693_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 98% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.791299
GSM967853U87-EV human glioblastoma xenograft - Control 210.953599
GSM967854U87-EV human glioblastoma xenograft - Control 311.025599
GSM967855U87-EV human glioblastoma xenograft - Control 411.886699
GSM967856U87-EV human glioblastoma xenograft - Control 511.204299
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.738999
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.274698
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.846899
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 411.11299
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.10399
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.009599
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.375999
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.118599
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 511.294399